ArticleWorld journal of gastrointestinal oncology2024

Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma.

Kun-Peng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.